Ken Skidmore is a Senior Scientist in the Analytical Operations
department at Genentech. Initially hired as an NMR spectroscopist
with a focus on qNMR, he now leads a group responsible for assessing
impurities during biologics drug development. His group uses a variety
of techniques (NMR, GC-MS, LC-MS, ICP-MS) to investigate extractables,
leachables, clearance of
process components, raw material composition,
and stock solution stability. In addition, he helps author leachables
documentation for BLA filings and manages outsourced work with
contract laboratories.
Read More